# Study to Assess the Effectiveness and Safety of FLECTOR Patch for Treatment of Acute Back Strain

> **NCT01054820** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 123 (actual)

## Conditions studied

- Acute Back Strain

## Interventions

- **DRUG:** FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%

## Key facts

- **NCT ID:** NCT01054820
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2012-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054820, "Study to Assess the Effectiveness and Safety of FLECTOR Patch for Treatment of Acute Back Strain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01054820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*